Stable Isotope Labelled Mogamulizumab Biosimilar – Anti-CCR4/CD194 mAb – Research Grade

Reference: PX-TA1258-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Mogamulizumab Biosimilar - Anti-CCR4/CD194 mAb - Research Grade
SourceCAS 1159266-37-1
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsAMG-761,KW-0761
ReferencePX-TA1258-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-CCR4/CD194[Homo sapiens] (Mogamulizumab) Monoclonal Antibody

Mogamulizumab targets CC chemokine receptor 4 (CCR4) and is used for the treatment of Mycosis Fungoides (MF) and Sézary Syndrome (SS) which are subtypes of cutaneous T-cell lymphoma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Mogamulizumab Biosimilar – Anti-CCR4/CD194 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products